Project profile — COVAX vaccine delivery and dose sharing mechanism



Overview 

CA-3-P010206004
$85,000,000
Gavi, The Vaccine Alliance (47122)
2022-12-20 - 2025-12-31
Operational
Global Affairs Canada
YFMInternaAssistPartnershp&Programing Br

Country / region 

• Africa, regional (60.00%)
• America, regional (10.00%)
• Asia, regional (10.00%)
• Oceania, regional (10.00%)
• Europe, regional (10.00%)

Sector 

• Health: COVID-19 control (12264) (100.00%)

Policy marker 

• Gender equality (significant objective)
• Environmental sustainability (cross-cutting) (not targeted)
• Participatory development and good governance (not targeted)
• Trade development (not targeted)
• Biodiversity (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Urban issues (not targeted)
• Desertification (not targeted)
• Children's issues (not targeted)
• Youth Issues (not targeted)
• Disaster Risk Reduction(DRR) (not targeted)
• Indigenous Issues (not targeted)
• Disability (not targeted)
• Nutrition (significant objective)
• ICT as a tool for development (not targeted)

Description 

This project aims to strengthen COVID-19 response and recovery by reducing COVID-19 related mortality and morbidity, particularly amongst vulnerable and priority-use populations in the Gavi Advance Market Commitment (AMC) 92 eligible economies. Through the Gavi COVAX Facility, support for the delivering and distributing COVID-19 vaccines would increase. The project supports the COVID-19 Delivery Support (CDS) envelope, which aims to accelerate vaccination to high-risk populations, scale-up vaccine delivery for target populations, and integrate COVID-19 into routine immunization and primary health systems. This project also provides CA$10M to Gavi to design and operationalize the dose- sharing mechanism and support dose donations, analysis and tracking. This represents additional funds provided to the project in response to the COVID-19 pandemic. The description and expected results are the same.

Expected results 

The expected outcomes of this project include: (1) increase access to COVID-19 vaccines for AMC 92 eligible economies, enabling the vaccination of high-priority populations, including healthcare workers, the elderly and vulnerable groups; (2) increase AMC 92 capacity to implement COVID-19 vaccination programs, including strengthened health system capacity to support the transition of COVID-19 vaccination programs into routine immunization programs as possible; and (3) increase and improve access to donated COVID-19 vaccines.

Results achieved 

N/A

Budget and spending 


Original budget $0
Planned disbursement $0
Transactions
Country percentages by sector
Type of finance Aid grant excluding debt reorganisation
Collaboration type Bilateral
Type of aid Contributions to specific-purpose programmes and funds managed by implementing partners
Date modified: